SIM
TMO icon

Studio Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Studio Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$344K Hold
686
– – 0.06% 156
2026
Q1 		$338K Buy
686
+1
+0.1% +$543 0.06% 143
2025
Q4 		$397K Sell
685
-6
-0.9% -$3.39K 0.07% 134
2025
Q3 		$335K Buy
691
+2
+0.3% +$931 0.06% 140
2025
Q2 		$280K Hold
689
– – 0.06% 155
2025
Q1 		$343K Sell
689
-47
-6% -$25.5K 0.07% 140
2024
Q4 		$383K Sell
736
-58
-7% -$31.9K 0.08% 124
2024
Q3 		$491K Buy
794
+26
+3% +$15.4K 0.1% 112
2024
Q2 		$425K Buy
768
+16
+2% +$9.17K 0.1% 111
2024
Q1 		$437K Buy
752
+51
+7% +$28.6K 0.1% 113
2023
Q4 		$372K Sell
701
-109
-13% -$52.8K 0.09% 116
2023
Q3 		$410K Buy
810
+42
+5% +$22.4K 0.11% 98
2023
Q2 		$401K Buy
768
+75
+11% +$40.5K 0.11% 101
2023
Q1 		$400K Buy
693
+2
+0.3% +$1.13K 0.12% 96
2022
Q4 		$381K Buy
691
+35
+5% +$18.5K 0.12% 92
2022
Q3 		$333K Buy
656
+4
+0.6% +$2.24K 0.12% 100
2022
Q2 		$354K Buy
652
+226
+53% +$124K 0.12% 95
2022
Q1 		$252K Buy
426
+18
+4% +$10.3K 0.08% 100
2021
Q4 		$272K Buy
408
+44
+12% +$27.5K 0.1% 101
2021
Q3 		$208K Buy
+364
New +$200K 0.09% 102

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Studio Investment Management's TMO Position: Q2 2026 in Review

Studio Investment Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 686 shares worth $344K. The position accounts for 0.06% of the portfolio, ranked #156.

Studio Investment Management first reported a position in TMO in Q3 2021 and has held it in 20 quarters since. The position peaked at $491K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Studio Investment Management held 686 shares of Thermo Fisher Scientific worth $344K as of Q2 2026.
  • Studio Investment Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.06% of Studio Investment Management's portfolio in Q2 2026, its #156 holding.
  • Studio Investment Management first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 20 quarters since.
  • Studio Investment Management's Thermo Fisher Scientific position peaked at $491K in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Studio Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.